Greenleaf Trust’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $869K | Sell |
7,350
-1,165
| -14% | -$134K | 0.01% | 395 |
|
|
2026
Q1 | $1.02M | Buy |
8,515
+1,022
| +14% | +$134K | 0.01% | 331 |
|
|
2025
Q4 | $1.02M | Sell |
7,493
-124
| -2% | -$17.8K | 0.01% | 329 |
|
|
2025
Q3 | $1.12M | Buy |
7,617
+212
| +3% | +$29.4K | 0.01% | 296 |
|
|
2025
Q2 | $958K | Sell |
7,405
-299
| -4% | -$36.2K | 0.01% | 321 |
|
|
2025
Q1 | $920K | Buy |
7,704
+387
| +5% | +$48K | 0.01% | 349 |
|
|
2024
Q4 | $849K | Buy |
7,317
+200
| +3% | +$25.3K | 0.01% | 370 |
|
|
2024
Q3 | $961K | Buy |
7,117
+59
| +0.8% | +$7.89K | 0.01% | 338 |
|
|
2024
Q2 | $957K | Sell |
7,058
-35
| -0.5% | -$4.76K | 0.01% | 306 |
|
|
2024
Q1 | $917K | Sell |
7,093
-58
| -0.8% | -$7.01K | 0.01% | 321 |
|
|
2023
Q4 | $818K | Sell |
7,151
-350
| -5% | -$34.9K | 0.01% | 325 |
|
|
2023
Q3 | $683K | Sell |
7,501
-513
| -6% | -$52.9K | 0.01% | 353 |
|
|
2023
Q2 | $903K | Buy |
8,014
+607
| +8% | +$64.2K | 0.01% | 305 |
|
|
2023
Q1 | $776K | Buy |
7,407
+118
| +2% | +$12.3K | 0.01% | 336 |
|
|
2022
Q4 | $806K | Buy |
7,289
+177
| +2% | +$18.6K | 0.01% | 319 |
|
|
2022
Q3 | $621K | Buy |
7,112
+415
| +6% | +$37.7K | 0.01% | 347 |
|
|
2022
Q2 | $524K | Sell |
6,697
-636
| -9% | -$52.5K | 0.01% | 376 |
|
|
2022
Q1 | $625K | Buy |
7,333
+496
| +7% | +$47.5K | 0.01% | 352 |
|
|
2021
Q4 | $820K | Buy |
6,837
+1,280
| +23% | +$159K | 0.01% | 295 |
|
|
2021
Q3 | $687K | Buy |
5,557
+621
| +13% | +$79.9K | 0.01% | 307 |
|
|
2021
Q2 | $592K | Buy |
4,936
+806
| +20% | +$92K | 0.01% | 354 |
|
|
2021
Q1 | $434K | Buy |
4,130
+490
| +13% | +$49.7K | 0.01% | 422 |
|
|
2020
Q4 | $371K | Sell |
3,640
-626
| -15% | -$58.8K | ﹤0.01% | 408 |
|
|
2020
Q3 | $359K | Buy |
4,266
+9
| +0.2% | +$701 | 0.01% | 367 |
|
|
2020
Q2 | $277K | Buy |
4,257
+939
| +28% | +$62K | ﹤0.01% | 420 |
|
|
2020
Q1 | $216K | Buy |
3,318
+653
| +25% | +$51.5K | ﹤0.01% | 414 |
|
|
2019
Q4 | $210K | Buy |
2,665
+24
| +0.9% | +$1.87K | ﹤0.01% | 507 |
|
|
2019
Q3 | $210K | Sell |
2,641
-264
| -9% | -$20.7K | ﹤0.01% | 512 |
|
|
2019
Q2 | $243K | Buy |
2,905
+50
| +2% | +$3.98K | ﹤0.01% | 457 |
|
|
2019
Q1 | $226K | Sell |
2,855
-179
| -6% | -$13.1K | ﹤0.01% | 465 |
|
|
2018
Q4 | $202K | Buy |
3,034
+310
| +11% | +$21.4K | ﹤0.01% | 458 |
|
|
2018
Q3 | $218K | Buy |
+2,724
| New | +$203K | ﹤0.01% | 483 |
|
|
2018
Q2 | – | Sell |
-1,490
| Closed | -$115K | – | 590 |
|
|
2018
Q1 | $115K | Hold |
1,490
| – | – | ﹤0.01% | 451 |
|
|
2017
Q4 | $102K | Buy |
1,490
+735
| +97% | +$48.8K | ﹤0.01% | 450 |
|
|
2017
Q3 | $47K | Buy |
+755
| New | +$45.1K | ﹤0.01% | 445 |
|
Other funds holding XYL
Greenleaf Trust's XYL Position: Q2 2026 in Review
Greenleaf Trust reduced its Xylem (XYL) stake by 14% in Q2 2026, selling an estimated $134K and leaving 7,350 shares worth $869K. The position accounts for 0.01% of the portfolio, ranked #395.
Greenleaf Trust first reported a position in XYL in Q3 2017 and has held it in 35 quarters since. The position peaked at $1.12M in Q3 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Greenleaf Trust held 7,350 shares of Xylem worth $869K as of Q2 2026.
- Greenleaf Trust sold 1,165 Xylem shares in Q2 2026, an estimated $134K.
- Xylem made up 0.01% of Greenleaf Trust's portfolio in Q2 2026, its #395 holding.
- Greenleaf Trust first reported a position in Xylem in Q3 2017 and has held it in 35 quarters since.
- Greenleaf Trust's Xylem position peaked at $1.12M in Q3 2025.
- 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.